BioSpace News Archive

Policy

Agilent Receives European IVDR Certification for Companion Diagnostic Assay

Agilent Technologies Inc. announced the issuing of a companion diagnostic Class C IVDR certification for PD-L1 IHC 22C3 pharmDx, Code SK006.

August 24, 2023
·
3 min read
Biotech Bay

Avinger Announces Presentations by Key Opinion Leaders at AMP (The Amputation Prevention Symposium) 2023

Avinger, Inc. announced three podium presentations featuring the company’s Lumivascular technology at The Amputation Prevention Symposium, held from August 16 through August 19 in Chicago, Illinois.

August 24, 2023
·
5 min read
Pharm Country

MiNK Therapeutics to Participate in September 2023 Investor Conferences

MiNK Therapeutics announced that Dr. Jennifer Buell, Chief Executive Officer and President, will participate in the following upcoming investor conferences.

August 24, 2023
·
1 min read
Ascendis Pharma A/S Announces Three Upcoming September 2023 Investor Presentations

Ascendis Pharma A/S announced that Jan Mikkelsen, President & Chief Executive Officer, and Scott Smith, Executive Vice President & Chief Financial Officer, will participate in three upcoming investor conferences.

August 24, 2023
·
4 min read
Genetown

Inhibikase Therapeutics Announces Development of Novel Formulation of risvodetinib

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company) today announced that it has developed a novel tablet formulation of IkT-148009, designed to improve drug exposure and overcome existing challenges related to patient use.

August 24, 2023
·
4 min read
Pharm Country

EmpiRx Health Applauds Blue Shield of California for Embracing a Value-based Prescription Drug Model, Announces Four-Point Plan to Accelerate PBM Transformation

EmpiRx Health, the leading value-based PBM company, applauds Blue Shield of California for joining it in implementing a value-based pharmacy care model.

August 24, 2023
·
4 min read
Pharm Country

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in September 2023

Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the Company will present at two healthcare industry conferences in September 2023.

August 24, 2023
·
3 min read
Business

Simulations Plus Chief Science Officer Dr. Viera Lukacova Honored as Fellow by the American Association of Pharmaceutical Scientists (AAPS)

Simulations Plus, Inc. is proud to announce that Dr. Viera Lukacova, Chief Science Officer of the SLP Division, has been elevated to the status of Fellow within the American Association of Pharmaceutical Scientists and will be formally inducted at the annual PharmSci 360 meeting on October 22, 2023.

August 24, 2023
·
3 min read
BioMidwest

Aptar Announces 2023 Investor Day

AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, will host an Investor Day on Friday, September 8, 2023.

August 24, 2023
·
1 min read
Drug Development

Preclinical Study Builds on Growing Body of Evidence Showcasing Exogenous Nicotinamide Mononucleotide (NMN) Must be Converted to Nicotinamide Riboside (NR), Making NR a More Efficient Nicotinamide Adenine Dinucleotide (NAD+) Precursor to NMN

ChromaDex Corp. as reported in the peer-reviewed journal International Journal of Molecular Sciences by a team of scientists led by Dr. Yue Yang, Assistant Professor of Research in Pharmacology at Weill Cornell Medicine in New York.

August 24, 2023
·
7 min read